Inflammation
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.4 | Q2 | 74.9% | 1.515 | Q1 | 92.2% |
| 2024 | 5.0 | Q1 | 77.7% | 1.270 | Q2 | 89.5% |
| 2023 | 4.5 | Q2 | 65.3% | 1.090 | Q2 | 87.5% |
| 2022 | 5.1 | Q2 | 63.5% | 0.941 | Q2 | 84.8% |
| 2021 | 4.7 | Q3 | 54.2% | 0.825 | Q2 | 82.0% |
| 2020 | — | — | 1.027 | Q2 | 85.9% | |
| 2019 | — | — | 0.927 | Q2 | 83.9% | |
| 2018 | — | — | 0.874 | Q2 | 80.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1573-2576
ISSN
0360-3997
country
UScoverage
1975-2005, 2007-2026